Process and system for obtaining botulinum neurotoxin | Patent Publication Number 20220033796

US 20220033796 A1
Patent NumberUS 11326155 B2
Application Number17505537
Filled DateOct 19, 2021
Priority DateJul 13, 2009
Publication DateFeb 3, 2022
Original AssigneeAbbvie Inc.
Current AssigneeAllergan
Inventor/ApplicantsHemant A. Patel
Jennifer L. Ton
Ronald C. Bates
Wajdie M. Ahmad
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.